Procalcitonin as a diagnostic and prognostic factor for tuberculosis meningitis

Journal of Clinical Neurology (Korea)

Volumn 12, Issue 3, 2016, Pages 332-339

  Kim, Jinseung ^a   Kim, Si Eun ^a   Park, Bong Soo ^a   Shin, Kyong Jin ^a   Ha, Sam Yeol ^a   Park, Jinse ^a   Kim, Sung Eun ^a   Park, Kang Min ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Bacteria; Procalcitonin; Prognosis; Tuberculosis

Indexed keywords

EID: 84978698514     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2016.12.3.332     Document Type: Article

References (28)

1. Garg RK. Tuberculous meningitis. Acta Neurol Scand 2010;122:75-90.
2. Yoon YK, Jo YM, Kwon HH, Yoon HJ, Lee EJ, Park SY, et al. Differential diagnosis between tuberculous spondylodiscitis and pyogenic spontaneous spondylodiscitis: a multicenter descriptive and comparative study. Spine J 2015;15:1764-1771.
3. Erdem H, Ozturk-Engin D, Tireli H, Kilicoglu G, Defres S, Gulsun S, et al. Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study. J Neurol 2015; 262:890-898.
4. Joosten AA, van der Valk PD, Geelen JA, Severin WP, Jansen Steur EN. Tuberculous meningitis: pitfalls in diagnosis. Acta Neurol Scand 2000;102:388-394.
5. Prat C, Domínguez J, Andreo F, Blanco S, Pallarés A, Cuchillo F, et al. Procalcitonin and neopterin correlation with aetiology and severity of pneumonia. J Infect 2006;52:169-177.
6. Huang CT, Lee LN, Ho CC, Shu CC, Ruan SY, Tsai YJ, et al. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis. J Infect 2014;68:440-447.
7. Huang SL, Lee HC, Yu CW, Chen HC, Wang CC, Wu JY, et al. Value of procalcitonin in differentiating pulmonary tuberculosis from other pulmonary infections: a meta-analysis. Int J Tuberc Lung Dis 2014; 18:440-447.
8. Viallon A, Zeni F, Lambert C, Pozzetto B, Tardy B, Venet C, et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis 1999;28:1313-1316.
9. Dubos F, Moulin F, Gajdos V, De Suremain N, Biscardi S, Lebon P, et al. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr 2006;149:72-76.
10. Kang YA, Kwon SY, Yoon HI, Lee JH, Lee CT. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia. Korean J Intern Med 2009;24:337-342.
11. Niu WY, Wan YG, Li MY, Wu ZX, Zhang LG, Wang JX. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis. Eur Rev Med Pharmacol Sci 2013;17:3329-3333.
12. Nyamande K, Lalloo UG. Serum procalcitonin distinguishes CAP due to bacteria, Mycobacterium tuberculosis and PJP. Int J Tuberc Lung Dis 2006;10:510-515.
13. Cakir E, Deniz O, Ozcan O, Tozkoparan E, Yaman H, Akgul EO, et al. Pleural fluid and serum procalcitonin as diagnostic tools in tuberculous pleurisy. Clin Biochem 2005;38:234-238.
14. Marais S, Thwaites G, Schoeman JF, Török ME, Misra UK, Prasad K, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis 2010;10:803-812.
15. Ropper AH, Samuels MA, Klein J. Adams and Victor’s Principles of Neurology. 10th ed. Columbus: McGraw-Hill Education, 2014;697-777.
16. Thwaites GE, Chau TT, Stepniewska K, Phu NH, Chuong LV, Sinh DX, et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002;360:1287-1292.
17. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-518.
18. Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Müller B. Expression and secretion of procalcitonin and calcitonin gene-relat-ed peptide by adherent monocytes and by macrophage-activated ad- ipocytes. Crit Care Med 2004;32:1715-1721.
19. Maruna P, Nedelníková K, Gürlich R. Physiology and genetics of procalcitonin. Physiol Res 2000;49 Suppl 1:S57-S61.
20. van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004;4:620-630.
21. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605-1608.
22. Alarcón F, Moreira J, Rivera J, Salinas R, Dueñas G, Van den Ende J. Tuberculous meningitis: do modern diagnostic tools offer better prognosis prediction? Indian J Tuberc 2013;60:5-14.
23. Hosoglu S, Geyik MF, Balik I, Aygen B, Erol S, Aygencel TG, et al. Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis 2002;6:64-70.
24. Hosoğlu S, Ayaz C, Geyik MF, Kökoğlu OF, Ceviz A. Tuberculous meningitis in adults: an eleven-year review. Int J Tuberc Lung Dis 1998; 2:553-557.
25. Ruokonen E, Ilkka L, Niskanen M, Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthe-siol Scand 2002;46:398-404.
26. Rasmussen TA, Søgaard OS, Camara C, Andersen PL, Wejse C. Serum procalcitonin in pulmonary tuberculosis. Int J Tuberc Lung Dis 2011; 15:251-256.
27. Hu R, Gong Y, Wang Y. Relationship of serum procalcitonin levels to severity and prognosis in pediatric bacterial meningitis. Clin Pediatr (Phila) 2015;54:1141-1144.
28. Chiang SS, Khan FA, Milstein MB, Tolman AW, Benedetti A, Starke JR, et al. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2014;14:947-957.